Christopher Ryan Sullivan insider trades

Open-market stock purchases and sales by Christopher Ryan Sullivan, Chief Financial Officer at Avalo Therapeutics, Inc, from SEC Form 4 filings since Jun 10, 2020.

Recent trades

DateStockTradeValue
Sep 16, 2026AVTX Avalo Therapeutics, IncSold$202K
Sep 16, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Sep 10, 2026AVTX Avalo Therapeutics, IncSold$179K
Sep 10, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Aug 18, 2026AVTX Avalo Therapeutics, IncSold$622K
Aug 18, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Aug 17, 2026AVTX Avalo Therapeutics, IncSold$753K
Aug 17, 2026AVTX Avalo Therapeutics, IncSold$74.8K
Aug 17, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Aug 17, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Jun 10, 2026AVTX Avalo Therapeutics, IncSold (not open market)$1.8K
May 21, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
May 7, 2026AVTX Avalo Therapeutics, IncSold$449K
May 7, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
May 6, 2026AVTX Avalo Therapeutics, IncSold$257K
May 6, 2026AVTX Avalo Therapeutics, IncSold$238K
May 6, 2026AVTX Avalo Therapeutics, IncSold$56.1K
May 6, 2026AVTX Avalo Therapeutics, IncSold$197K
May 6, 2026AVTX Avalo Therapeutics, IncSold$201K
May 6, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Apr 30, 2026AVTX Avalo Therapeutics, IncSold$112K
Apr 29, 2026AVTX Avalo Therapeutics, IncSold$111K
Apr 2, 2026AVTX Avalo Therapeutics, IncSold$106K
Apr 2, 2026AVTX Avalo Therapeutics, IncSold$31.3K
Apr 1, 2026AVTX Avalo Therapeutics, IncSold$7.9K

Companies traded

  • AVTX Avalo Therapeutics, Inc: 2 buys, 17 sales, last Sep 16, 2026
  • CERC Cerecor Inc: 2 buys, last Jan 26, 2021

Get free alerts when Christopher Ryan Sullivan files a new trade →